🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Impedance Plethysmography Based Deep Vein Thrombosis Monitoring During Catheter-directed Thrombolysis

Recruitingn/aAges 18 Years - anyAllTampere University
NCT07665320 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this study is to collect data on blood circulation using a multi-frequency impedance plethysmography device developed in the ThrombUS+ project. Impedance plethysmography (IPG) is a non-invasive method that measures changes in blood volume using electrodes placed on the skin. The collected data will be used for device development, the improvement of diagnostic data analysis methods, and AI training. A total of 40 participants will be recruited for this study, with 20 healthy volunteers in Tampere University and 20 patients undergoing thrombolytic therapy for DVT at Tampere University Hospital.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria for Patients group: * Age: 18 or older; * DVT detected on other lower limb; * Suitable for CDT treatment; * Ability to give informed consent; * Volunteering for the study. Exclusion Criteria for Patients group: * Age under 18 years; * Inability to give informed consent; * Denial; * Too injured skin in the measurement area Inclusion Criteria for Healthy volunteers group: * Age: 18 or older; * Ability to give informed consent; * Volunteering for the study Exclusion Criteria for Healthy volunteers group: * Diagnosed DVT in lower limbs; * Age under 18 years; * Inability to give informed consent; * Denial; * Too injured skin in the measurement area.
💊

What it tests

  • Impedance plethysmography IPG
  • Venous Occlusion Plethysmography VOP
  • Breathing and leg movement exercise
📍

Where

2 sites
Tampere University Hospital
Tampere, Finland
Tampere University
Tampere, Finland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy